Preeclampsia: integrated network model of platelet biomarkers interaction as a tool to evaluate the

Letícia Gonçalves Freitas1, Renato Sathler-Avelar2, Danielle Marquete Vitelli-Avelar2

  • 1Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia-Universidade Federal de Minas Gerais, Brazil.

Insights

Preeclampsia (PE) is not linked to higher platelet activation markers. Researchers found no single biomarker for diagnosing or predicting PE, despite observed correlations in severe cases.

Area of Science:

  • Obstetrics and Gynecology
  • Hematology
  • Immunology

Background:

  • Preeclampsia (PE) is linked to platelet activation, potentially driving coagulation and inflammation.
  • Investigating platelet activation, platelet-leukocyte aggregates (PLA), and monocyte tissue factor (TF) as diagnostic biomarkers for PE.

Purpose of the Study:

  • To determine if platelet activation markers, PLA, and monocyte TF expression can serve as biomarkers for preeclampsia diagnosis and prognosis.

Main Methods:

  • Flow cytometry was used to analyze platelet markers in 97 women (severe PE, mild PE, normotensive pregnant, non-pregnant).
  • Evaluated platelet counts, CD41a and CD61 expression, PLA frequency, and monocyte TF expression.

Main Results:

  • Platelet counts and CD41a expression were lower in non-pregnant and severe PE groups compared to non-pregnant controls.
  • No significant differences in PLA and monocyte TF expression were found among groups.
  • Correlations between platelet activation markers were noted, particularly in severe PE, suggesting hemostatic/immunological interplay.

Conclusions:

  • Preeclampsia is not associated with elevated platelet activation markers.
  • No single laboratorial biomarker was identified for PE diagnosis or prognosis.
  • The role of platelet activation in PE pathophysiology requires further investigation.
Abstract

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.2K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.7K
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
7.0K
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
14.0K